SCHEMBL7309706

SCHEMBL7309706

CN1CCC(CSc2ccc(Oc3ccc(Cl)cc3)cc2)(C(=O)NO)CC1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 12/20 0.57
▸ MMP9 P14780 11/20 0.57
▸ MMP1 P03956 11/20 0.57
▸ ADAM17 P78536 7/20 0.57
▸ MMP3 P08254 5/20 0.46
▸ MMP14 P50281 4/20 0.46
▸ MMP2 P08253 4/20 0.46
▸ MMP7 P09237 3/20 0.46
▸ MMP8 P22894 3/20 0.46
▸ MMP10 P09238 2/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ADAMTS4 O75173 1/20 0.42
▸ ADAMTS5 Q9UNA0 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304852 0.89 MMP13 (0.45) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7309299 0.84 MMP1 (0.46) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7304591 0.84 MMP1 (0.64) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7310855 0.84 MMP13 (0.56) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7309131 0.80 MMP1 (0.39) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7301851 0.79 MMP13 (0.73) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7297023 0.79 ALDH1A1 (0.47) SMN1; SMN2LMNAALDH1A1GAA
SCHEMBL6998853 0.77 MMP1 (0.56) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL7001941 0.77 MMP1 (0.56) MMP13MMP9MMP1ADAM17MMP3
SCHEMBL13898934 0.74 MMP13 (0.48) MMP13MMP9MMP1ADAM17MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 — — EP disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 — — EP disclosed
Send feedback